Dr. A. John Iafrate discusses the practical challenges of clinical genotyping and how Anchored Multiplex PCR (AMP) technology addresses those challenges for fusion, CNV, SNV, and RNA expression detection, while giving clinical scenarios in which AMP has been advantageous. Dr. Iafrate also discusses the benefit of comprehensive next-generation sequencing (NGS) technologies in the study of cancer biomarkers.
Watch the webinar below to get in-depth information on the use of AMP and comprehensive NGS technology in the clinic.
Dr. Iafrate is a board-certified pathologist at Massachusetts General Hospital. He oversees the Center for Integrated Diagnostics, which provides rapid personalized genomic testing to help inform cancer treatment decisions for patients. Prior to working for Massachusetts General Hospital and Harvard University, Dr. Iafrate received his MD and PhD from State University of New York at Stony Brook and subsequently trained at Brigham and Women's Hospital for Anatomic and Molecular Genetic Pathology.
2477 55th Street, Suite 202
Boulder, CO 80301